作者: Erik Liederbach , Carol M. Lewis , Katharine Yao , Bruce E. Brockstein , Chi-Hsiung Wang
DOI: 10.1245/S10434-015-4560-X
关键词: Cancer 、 Tonsil 、 Internal medicine 、 Transoral robotic surgery 、 Surgery 、 Surgical oncology 、 Survival rate 、 Medicine 、 Carcinoma 、 Stage (cooking) 、 Young adult
摘要: This study examined surgical trends for oropharynx squamous cell carcinoma (OPC) from 1998 to 2012, with a post-2009 focus coinciding the Food and Drug Administration (FDA) approval of transoral robotic surgery (TORS). Using National Cancer Data Base, analyzed 84,449 patients with stage I-IVB OPC. χ 2 tests logistic regression models were used examine trends. The use decreased 41.4 % in 30.4 % 2009 (p < 0.001). reversed 2012 increased 34.8 % There was much variation between American Joint Committee on stages, 80.2 % stage I receiving compared 54.0 % II patients, 36.8 % III 28.5 % IV Black high socioeconomic status (SES) showed lower (25.3 %) low SES white (32.3 %) Hispanic (27.3 %) highest rates noted West North Central region lowest observed New England South Atlantic regions. Between independent predictors treatment included young age, female gender, or race, SES, private insurance, academic hospitals, hospitals region, residence more than 75 miles hospital, increasing comorbidities, disease, tonsil origin (all p < 0.05). Since FDA TORS 2009, have multiple regional factors affecting patient selection. provides basis further investigation into involved decision making OPC patients.